Business Context and Reporting Period
This Form 8-K reports on the Annual General Meeting of Shareholders held by Constellium SE on May 21, 2026. The filing details the voting outcomes for director appointments, executive compensation advisory votes, and the approval of financial statements for the fiscal year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance voting results and the approval of previously issued financial statements.
Material Changes and Voting Results
- Board of Directors: Shareholders approved the appointment of Ingrid Joerg and the re-appointment of John Ormerod for three-year terms.
- Executive Compensation Frequency: Shareholders voted to hold an advisory (non-binding) vote on executive compensation annually, rejecting biennial and triennial options.
- Financial Statement Approval: The statutory and consolidated financial statements for the fiscal year ended December 31, 2025, were approved with overwhelming support (over 107 million votes for).
- Share Repurchase Authorization: The Board was authorized to repurchase shares, reduce share capital by canceling acquired shares, and reduce capital by canceling shares acquired under specific French Commercial Code provisions.
- Discharge of Duties: Directors, the CEO, and Statutory Auditors received discharge for their performance during the 2025 fiscal year, though a notable portion of votes (approx. 13 million) were cast against this proposal.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. No specific risks or contingencies are detailed in this report beyond the standard disclosure of voting results.
Investor Verification Checklist
- Verify the full text of the 2025 Annual Report to review the financial statements approved by shareholders.
- Review the specific terms of the newly authorized share repurchase program and capital reduction plans.
- Monitor the implementation of the annual advisory vote on executive compensation as mandated by the shareholder resolution.
- Confirm the effective dates for the new and re-appointed board members (Ingrid Joerg and John Ormerod).